Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D01GVC
|
|||
| Former ID |
DIB002166
|
|||
| Drug Name |
GP-3269
|
|||
| Synonyms |
GP-1-3269
Click to Show/Hide
|
|||
| Indication | Convulsion [ICD-11: 8A68.Z; ICD-9: 780.3] | Phase 1 | [1] | |
| Company |
Metabasis Therapeutics Inc
|
|||
| Structure |
 |
Download2D MOL |
||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Adenosine kinase (ADK) | Target Info | Inhibitor | [1] |
| BioCyc | Superpathway of purine nucleotide salvage | |||
| Adenine and adenosine salvage II | ||||
| KEGG Pathway | Purine metabolism | |||
| Metabolic pathways | ||||
| Reactome | Purine salvage | |||
| WikiPathways | Metabolism of nucleotides | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Adenosine kinase inhibitors. 6. Synthesis, water solubility, and antinociceptive activity of 5-phenyl-7-(5-deoxy-beta-D-ribofuranosyl)pyrrolo[2,3-d]pyrimidines substituted at C4 with glycinamides andrelated compounds. J Med Chem. 2005 Dec 1;48(24):7808-20. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.